UBS AM’s Oramed Pharmaceuticals ORMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$701 Buy
+150
New +$678 ﹤0.01% 4160

Other funds holding ORMP

UBS AM's ORMP Position: Q3 2026 in Review

UBS AM opened a new position in Oramed Pharmaceuticals (ORMP) in Q3 2026: 150 shares worth $701. The stake represents ﹤0.01% of the portfolio and ranks #4160 among its holdings.

79 funds tracked by Wall St. Rank hold ORMP as of Q3 2026.

  • UBS AM held 150 shares of Oramed Pharmaceuticals worth $701 as of Q3 2026.
  • Oramed Pharmaceuticals was a new UBS AM position in Q3 2026.
  • Oramed Pharmaceuticals made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #4160 holding.
  • 79 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q3 2026.

Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.